A Backwards Approach: Expanded Access Drives Tpoxx Trial Design That Limits Placebo Control
Executive Summary
US may be making common crisis-era mistake with Tpoxx trial design that prioritizes access over knowledge, ultimately restraining development of data needed to make the best treatment decisions with the potential Monkeypox treatment, particularly for the most vulnerable patients.